Newswise — The US Food and Drug Administration has approved a flu vaccine to be taken at home.
FluMist is a nasal spray by AstraZencea which has been on the market since 2003 to protect against the respiratory virus. However, the FDA just approved that it can be administered at home.
The company will make the vaccine available through a third-party online pharmacy which will then be prescribed and shipped to your home.
This option, however, will not be available for the start of the flu season.
Faculty experts at the George Washington University are available to offer insight about respiratory season and the new FDA approval. To schedule an interview with an expert, please contact Katelyn Deckelbaum at [email protected].
Michael Knight is an assistant professor of medicine at the GW School of Medicine and Health Sciences.
David Diemert is the clinical director of the GW Vaccine Research unit and professor of medicine at the GW School of Medicine and Health Sciences.
Emily Smith, is an associate professor of global health and an expert in infectious diseases and epidemiology, at the GW Milken Institute School of Public Health.
Maria Elena Ruiz is an associate professor of medicine and an infectious disease expert at the GW School of Medicine and Health Sciences.
Adriana Glenn is an assistant professor in the GW School of Nursing.
-GW-
RSS